4//SEC Filing
Drake Neil 4
Accession 0001214659-18-003244
CIK 0001427570other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 7:23 AM ET
Size
4.8 KB
Accession
0001214659-18-003244
Insider Transaction Report
Form 4
Drake Neil
VP of Research and Development
Transactions
- Award
Common Stock
2018-04-30$3.27/sh+2,743$8,970→ 29,593 total
Footnotes (1)
- [F1]These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001698005
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 7:23 AM ET
- Size
- 4.8 KB